Based on expression of high levels of TNF-α, IFN-γ, and granzyme B, CD8+ TRM cell infiltration in various human cancers is correlated with favorable clinical outcomes, and CD8+ TRM cells have emerged as a predictive marker of survival in several human epithelial cancers (35–40). This evidence concerns the gene CD8A and cancer.